For many innovators, the real challenge begins after the MVP stage. Moving from a promising prototype to a fully integrated, compliant and manufacturable medical device requires deep technical expertise, regulatory insight and a structured development process.
This co-hosted webinar for members of the Connected Health & Wellbeing Cluster and MedLink Cluster Galway, brings together innovators from across the ecosystem to explore what it truly takes to progress from MVP to a market-ready, integrated medical device.
We are delighted to welcome Comate, a leading Belgian engineering and design company, to speak with our cluster members about bringing hardware innovations successfully from idea to market.
Founded in 2010, Comate has grown to a team of more than 90 engineers and designers, delivering over 800 successful projects across healthcare, life sciences, industrial machinery and high-tech sectors. The company supports organisations from early concept development and user insight through engineering design, verification, certification and industrialisation.
Designed specifically for our cluster members, this session will explore:
- How to transition from MVP to an integrated medical device
- De-risking technology through proof of concept and structured validation
- Bridging usability, engineering feasibility and regulatory compliance
- Designing for manufacturability, scale and cost control
- Practical lessons from complex implantable and regulated device projects
This joint event offers a valuable opportunity for members of both clusters to gain practical insight, connect across regions, and understand how to give their medical innovation the best possible chance to succeed.
The Connected Health & Wellbeing Cluster and MedLink Galway are two of 12 sectoral clusters funded by Enterprise Ireland through the Regional Technology Cluster Fund (visit the Enterprise Ireland website). The clusters facilitate collaborations between members to enable R,D&I value add opportunities and increase competitiveness of start-ups, indigenous SME’s and multinational companies.
